Suchergebnisse - "Ramanathan, Ramesh K"

PubPharm (369)

1

Genomic landscape of diploid and aneuploid microsatellite stable early onset colorectal cancer

enthalten in: Scientific reports | 2024

von Zhou, Y. | Chen, X. | Chen, J. | +6

2

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Goldberg, R. | Sargent, D. | Morton, R. | +6

RepublishedFrom: J Clin Oncol. 2004 Jan 1;22(1):23-30. - PMID 14665611

3

Métodos y materiales para evaluar y tratar el cáncer

enthalten in: Europäisches Patentamt | 2021

von POCKAJ BARBARA A | BARRETT MICHAEL T | BORAD MITESH J | +2

4

Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors

enthalten in: Molecular cancer therapeutics | 2021

von Gordon, M. | Nemunaitis, J. | Barve, M. | +12

5

Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors

enthalten in: Clinical colorectal cancer | 2021

von Ando, K. | Ozonoff, A. | Lee, S. | +20

6

Correction to : Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer

enthalten in: Targeted oncology | 2020

von Ramanathan, R. | Von Hoff, D. | Eskens, F. | +8

ErratumFor: Target Oncol. 2020 Apr;15(2):163-174. - PMID 32314268

7

Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer

enthalten in: Targeted oncology | 2020

von Ramanathan, R. | Von Hoff, D. | Eskens, F. | +8

8

Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer

enthalten in: Targeted oncology | 2020

von Ramanathan, R. | Von Hoff, D. | Eskens, F. | +8

9

Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer

enthalten in: Targeted oncology | 2020

von Ramanathan, R. | Von Hoff, D. | Eskens, F. | +8

10

Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours

enthalten in: British journal of clinical pharmacology | 2020

von Mahalingam, D. | Patel, M. | Sachdev, J. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[37]